TTNP logo

Titan Pharmaceuticals (TTNP) Total Assets

Annual Total Assets

$8.09 M
+$4.03 M+99.26%

December 31, 2023


Summary


Performance

TTNP Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTTNPbalance sheetmetrics:

Quarterly Total Assets

$3.60 M
-$748.00 K-17.20%

September 30, 2024


Summary


Performance

TTNP Quarterly Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTTNPbalance sheetmetrics:

Total Assets Formula

Total Assets = Current Assets + Non-Current Assets

TTNP Total Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+99.3%-55.5%
3 y3 years-0.0%-65.1%
5 y5 years-42.6%-73.9%

TTNP Total Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+99.3%-65.1%+343.6%
5 y5-year-15.1%+99.3%-73.9%+343.6%
alltimeall time-93.2%+117.0%-97.0%+343.6%

Titan Pharmaceuticals Total Assets History

DateAnnualQuarterly
Sep 2024
-
$3.60 M(-17.2%)
Jun 2024
-
$4.35 M(-34.5%)
Mar 2024
-
$6.65 M(-17.8%)
Dec 2023
$8.09 M(+99.3%)
$8.09 M(-19.1%)
Sep 2023
-
$10.00 M(+1131.4%)
Jun 2023
-
$812.00 K(-62.5%)
Mar 2023
-
$2.17 M(-46.6%)
Dec 2022
$4.06 M(-49.2%)
$4.06 M(-35.3%)
Sep 2022
-
$6.28 M(-24.6%)
Jun 2022
-
$8.32 M(-19.4%)
Mar 2022
-
$10.32 M(+29.1%)
Dec 2021
$7.99 M(-1.1%)
$7.99 M(-17.0%)
Sep 2021
-
$9.64 M(-16.3%)
Jun 2021
-
$11.51 M(-16.8%)
Mar 2021
-
$13.82 M(+70.9%)
Dec 2020
$8.09 M(-15.1%)
$8.09 M(+0.9%)
Sep 2020
-
$8.02 M(-17.9%)
Jun 2020
-
$9.76 M(-26.4%)
Mar 2020
-
$13.26 M(+39.3%)
Dec 2019
$9.52 M(-32.4%)
$9.52 M(+79.5%)
Sep 2019
-
$5.30 M(-21.6%)
Jun 2019
-
$6.76 M(-40.9%)
Mar 2019
-
$11.44 M(-18.8%)
Dec 2018
$14.10 M(+58.3%)
$14.10 M(+18.9%)
Sep 2018
-
$11.85 M(+156.7%)
Jun 2018
-
$4.62 M(-12.7%)
Mar 2018
-
$5.29 M(-40.6%)
Dec 2017
$8.90 M(-52.3%)
$8.90 M(-30.1%)
Sep 2017
-
$12.74 M(+35.3%)
Jun 2017
-
$9.41 M(-28.0%)
Mar 2017
-
$13.07 M(-30.0%)
Dec 2016
$18.67 M(+40.5%)
$18.67 M(-20.7%)
Sep 2016
-
$23.54 M(-7.0%)
Jun 2016
-
$25.30 M(+110.9%)
Mar 2016
-
$12.00 M(-9.7%)
Dec 2015
$13.29 M(-36.3%)
$13.29 M(-10.9%)
Sep 2015
-
$14.91 M(-13.9%)
Jun 2015
-
$17.31 M(-5.8%)
Mar 2015
-
$18.39 M(-11.8%)
Dec 2014
$20.85 M(+13.2%)
$20.85 M(+57.8%)
Sep 2014
-
$13.22 M(-7.2%)
Jun 2014
-
$14.25 M(-11.6%)
Mar 2014
-
$16.12 M(-12.5%)
Dec 2013
$18.42 M(-25.8%)
$18.42 M(+18.7%)
Sep 2013
-
$15.52 M(-8.2%)
Jun 2013
-
$16.91 M(-28.1%)
Mar 2013
-
$23.53 M(-5.2%)
Dec 2012
$24.83 M(+143.0%)
$24.83 M(+131.1%)
Sep 2012
-
$10.74 M(+6.9%)
Jun 2012
-
$10.05 M(+33.9%)
Mar 2012
-
$7.51 M(-26.5%)
Dec 2011
$10.22 M(+115.0%)
$10.22 M(+56.0%)
Sep 2011
-
$6.55 M(-25.9%)
Jun 2011
-
$8.84 M(+174.7%)
Mar 2011
-
$3.22 M(-32.3%)
Dec 2010
$4.75 M
$4.75 M(-44.4%)
DateAnnualQuarterly
Sep 2010
-
$8.55 M(+309.7%)
Jun 2010
-
$2.09 M(-72.0%)
Mar 2010
-
$7.45 M(+99.9%)
Dec 2009
$3.73 M(-87.9%)
$3.73 M(-72.4%)
Sep 2008
-
$13.50 M(-30.7%)
Jun 2008
-
$19.47 M(-24.4%)
Mar 2008
-
$25.74 M(-16.6%)
Dec 2007
$30.84 M(+105.1%)
$30.84 M(+114.3%)
Sep 2007
-
$14.39 M(-22.9%)
Jun 2007
-
$18.68 M(+58.4%)
Mar 2007
-
$11.79 M(-21.6%)
Dec 2006
$15.04 M(-23.8%)
$15.04 M(-19.8%)
Sep 2006
-
$18.75 M(-13.6%)
Jun 2006
-
$21.70 M(-13.8%)
Mar 2006
-
$25.15 M(+27.4%)
Dec 2005
$19.74 M(-48.9%)
$19.74 M(-6.9%)
Sep 2005
-
$21.20 M(-20.0%)
Jun 2005
-
$26.50 M(-20.0%)
Mar 2005
-
$33.14 M(-14.2%)
Dec 2004
$38.63 M(-21.2%)
$38.63 M(-15.3%)
Sep 2004
-
$45.58 M(-10.5%)
Jun 2004
-
$50.93 M(-12.4%)
Mar 2004
-
$58.14 M(+18.6%)
Dec 2003
$49.01 M(-35.5%)
$49.01 M(-13.0%)
Sep 2003
-
$56.32 M(-10.2%)
Jun 2003
-
$62.73 M(-9.5%)
Mar 2003
-
$69.29 M(-8.7%)
Dec 2002
$75.93 M(-29.1%)
$75.93 M(-9.7%)
Sep 2002
-
$84.04 M(-8.6%)
Jun 2002
-
$91.92 M(-7.0%)
Mar 2002
-
$98.88 M(-7.7%)
Dec 2001
$107.13 M(-9.5%)
$107.13 M(-3.0%)
Sep 2001
-
$110.49 M(-3.5%)
Jun 2001
-
$114.47 M(-1.2%)
Mar 2001
-
$115.87 M(-2.2%)
Dec 2000
$118.44 M(+149.9%)
$118.44 M(+46.9%)
Sep 2000
-
$80.63 M(-3.5%)
Jun 2000
-
$83.51 M(-2.7%)
Mar 2000
-
$85.80 M(+81.0%)
Dec 1999
$47.40 M(+288.5%)
$47.40 M(+388.7%)
Sep 1999
-
$9.70 M(-21.8%)
Jun 1999
-
$12.40 M(-19.5%)
Mar 1999
-
$15.40 M(+26.2%)
Dec 1998
$12.20 M(-52.3%)
$12.20 M(-18.7%)
Sep 1998
-
$15.00 M(-15.3%)
Jun 1998
-
$17.70 M(-11.5%)
Mar 1998
-
$20.00 M(-21.9%)
Dec 1997
$25.60 M(+56.1%)
$25.60 M(+224.1%)
Sep 1997
-
$7.90 M(-42.8%)
Jun 1997
-
$13.80 M(+30.2%)
Mar 1997
-
$10.60 M(-35.4%)
Dec 1996
$16.40 M(+248.9%)
$16.40 M(-16.8%)
Sep 1996
-
$19.70 M(+123.9%)
Jun 1996
-
$8.80 M(-25.4%)
Mar 1996
-
$11.80 M(+151.1%)
Dec 1995
$4.70 M
$4.70 M

FAQ

  • What is Titan Pharmaceuticals annual total assets?
  • What is the all time high annual total assets for Titan Pharmaceuticals?
  • What is Titan Pharmaceuticals annual total assets year-on-year change?
  • What is Titan Pharmaceuticals quarterly total assets?
  • What is the all time high quarterly total assets for Titan Pharmaceuticals?
  • What is Titan Pharmaceuticals quarterly total assets year-on-year change?

What is Titan Pharmaceuticals annual total assets?

The current annual total assets of TTNP is $8.09 M

What is the all time high annual total assets for Titan Pharmaceuticals?

Titan Pharmaceuticals all-time high annual total assets is $118.44 M

What is Titan Pharmaceuticals annual total assets year-on-year change?

Over the past year, TTNP annual total assets has changed by +$4.03 M (+99.26%)

What is Titan Pharmaceuticals quarterly total assets?

The current quarterly total assets of TTNP is $3.60 M

What is the all time high quarterly total assets for Titan Pharmaceuticals?

Titan Pharmaceuticals all-time high quarterly total assets is $118.44 M

What is Titan Pharmaceuticals quarterly total assets year-on-year change?

Over the past year, TTNP quarterly total assets has changed by -$4.48 M (-55.45%)